Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs MEDICO REMEDIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES MEDICO REMEDIES DIVIS LABORATORIES/
MEDICO REMEDIES
 
P/E (TTM) x 86.4 48.3 178.9% View Chart
P/BV x 11.7 7.1 165.1% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 DIVIS LABORATORIES   MEDICO REMEDIES
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-24
MEDICO REMEDIES
Mar-24
DIVIS LABORATORIES/
MEDICO REMEDIES
5-Yr Chart
Click to enlarge
High Rs4,072101 4,040.4%   
Low Rs2,82545 6,284.6%   
Sales per share (Unadj.) Rs295.517.5 1,692.1%  
Earnings per share (Unadj.) Rs60.31.0 6,032.1%  
Cash flow per share (Unadj.) Rs74.51.3 5,535.2%  
Dividends per share (Unadj.) Rs30.000-  
Avg Dividend yield %0.90-  
Book value per share (Unadj.) Rs511.26.3 8,099.9%  
Shares outstanding (eoy) m265.4782.98 319.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x11.74.2 279.7%   
Avg P/E ratio x57.272.9 78.5%  
P/CF ratio (eoy) x46.354.1 85.5%  
Price / Book Value ratio x6.711.5 58.4%  
Dividend payout %49.80-   
Avg Mkt Cap Rs m915,5086,047 15,139.8%   
No. of employees `000NANA-   
Total wages/salary Rs m10,94059 18,479.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m78,4501,449 5,413.3%  
Other income Rs m3,39021 15,923.0%   
Total revenues Rs m81,8401,470 5,565.5%   
Gross profit Rs m22,060129 17,088.9%  
Depreciation Rs m3,78029 13,129.6%   
Interest Rs m408 485.4%   
Profit before tax Rs m21,630113 19,082.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,63030 18,495.4%   
Profit after tax Rs m16,00083 19,298.0%  
Gross profit margin %28.18.9 315.7%  
Effective tax rate %26.026.9 96.9%   
Net profit margin %20.45.7 356.5%  
BALANCE SHEET DATA
Current assets Rs m101,520758 13,396.9%   
Current liabilities Rs m17,550446 3,936.7%   
Net working cap to sales %107.021.5 497.2%  
Current ratio x5.81.7 340.3%  
Inventory Days Days126 215.3%  
Debtors Days Days101,250 0.8%  
Net fixed assets Rs m57,850224 25,790.2%   
Share capital Rs m530166 319.3%   
"Free" reserves Rs m135,180358 37,787.2%   
Net worth Rs m135,710524 25,913.2%   
Long term debt Rs m02 0.0%   
Total assets Rs m159,370982 16,227.5%  
Interest coverage x541.814.8 3,671.7%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.51.5 33.4%   
Return on assets %10.19.3 108.4%  
Return on equity %11.815.8 74.5%  
Return on capital %16.023.1 69.1%  
Exports to sales %85.296.1 88.7%   
Imports to sales %24.07.4 325.9%   
Exports (fob) Rs m66,8701,393 4,799.0%   
Imports (cif) Rs m18,810107 17,642.1%   
Fx inflow Rs m66,8701,393 4,799.0%   
Fx outflow Rs m19,160108 17,696.5%   
Net fx Rs m47,7101,285 3,712.4%   
CASH FLOW
From Operations Rs m12,61024 51,722.7%  
From Investments Rs m-2,690-27 10,048.6%  
From Financial Activity Rs m-7,990-5 163,061.2%  
Net Cashflow Rs m1,930-7 -26,474.6%  

Share Holding

Indian Promoters % 51.9 73.3 70.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 38.3 1.2 3,219.3%  
FIIs % 17.3 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 26.7 180.5%  
Shareholders   278,899 12,887 2,164.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    ZYDUS LIFESCIENCES    


More on Divis Laboratories vs MEDICO REMEDIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Divis Laboratories vs MEDICO REMEDIES Share Price Performance

Period Divis Laboratories MEDICO REMEDIES S&P BSE HEALTHCARE
1-Day 1.35% -1.97% 0.11%
1-Month 0.88% -11.22% -3.22%
1-Year 60.59% -42.51% 42.65%
3-Year CAGR 8.49% 18.06% 19.86%
5-Year CAGR 27.91% 62.45% 25.90%

* Compound Annual Growth Rate

Here are more details on the Divis Laboratories share price and the MEDICO REMEDIES share price.

Moving on to shareholding structures...

The promoters of Divis Laboratories hold a 51.9% stake in the company. In case of MEDICO REMEDIES the stake stands at 73.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Divis Laboratories and the shareholding pattern of MEDICO REMEDIES .

Finally, a word on dividends...

In the most recent financial year, Divis Laboratories paid a dividend of Rs 30.0 per share. This amounted to a Dividend Payout ratio of 49.8%.

MEDICO REMEDIES paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Divis Laboratories, and the dividend history of MEDICO REMEDIES .

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Falls 423 Points | Nifty Ends Near 23,350 | Adani Enterprises Cracks 23% Sensex Today Falls 423 Points | Nifty Ends Near 23,350 | Adani Enterprises Cracks 23%(Closing)

On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.